1. Stocks
  2. Kala Pharmaceuticals Inc
  3. Swot
swot-logo

Kala Pharmaceuticals Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Kala Pharmaceuticals Inc has 16 Strengths, 8 Weaknesses, 4 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Relative Outperformance versus Industry over 1 Week

Significant (over 30%) distance from 52 week high

Relative Outperformance versus Industry over 1 Month

Rising Net Cash Flow and Cash from Operating activity

Relative Outperformance versus Industry over the Quarter (3 Months)

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Stock gained more than 20% in one month

Annual Net Profits improving for last 2 years

Stock with Low PE (PE < = 10)

RSI indicating price strength

Stocks Outperforming their Industry Price Change in the Quarter

Companies with High Debt

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Inefficient use of shareholder funds - ROE declining in the last 2 years

Inefficient use of assets to generate profits - ROA declining in the last 2 years

Highest fall from 52 Week High

Top Losers

Low Piotroski Score : Companies with weak financials

Top Losers

Mutual Funds Increased Shareholding in Past Month

Mutual Funds Increased Shareholding over the Past Two Months

MFs increased their shareholding last quarter

Mf buying for 2 months

Promoters increasing shareholding QoQ

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks